| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tim D Aumann, Mai Raabus, Doris Tomas, Agustinus Prijanto, Leonid Churilov, Nicholas C Spitzer, Malcolm K Horn. Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans. PloS one. vol 11. issue 7. 2017-07-26. PMID:27428306. |
recent evidence indicates the number of dopaminergic neurons in the adult rodent hypothalamus and midbrain is regulated by environmental cues, including photoperiod, and that this occurs via up- or down-regulation of expression of genes and proteins that are important for dopamine (da) synthesis in extant neurons ('da neurotransmitter switching'). |
2017-07-26 |
2023-08-13 |
Not clear |
| I Morales, L Font, P J Currie, R Pasto. Involvement of opioid signaling in food preference and motivation: Studies in laboratory animals. Progress in brain research. vol 229. 2017-07-10. PMID:27926437. |
different neurotransmitter systems, particularly the mesolimbic dopaminergic system, have been associated with food motivation. |
2017-07-10 |
2023-08-13 |
rat |
| Stephen M Stah. Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome. CNS spectrums. vol 21. issue 5. 2017-06-29. PMID:27686027. |
parkinson's disease psychosis (pdp) is theoretically a serotonin-dopamine imbalance syndrome due to disruption of the normal balance between the serotonergic and dopaminergic neurotransmitter systems in key brain circuits. |
2017-06-29 |
2023-08-13 |
Not clear |
| Lauren E Sweet, Joseph H Bisesi, E N Y Lei, Michael H W Lam, Stephen J Klain. The effects of bupropion on hybrid striped bass brain chemistry and predatory behavior. Environmental toxicology and chemistry. vol 35. issue 8. 2017-06-28. PMID:26748934. |
the objective of the present study was to understand if alteration of dopaminergic neurotransmitter concentrations in the hybrid striped bass (morone saxatilis × morone chrysops) brain by bupropion would alter this predator's ability to capture prey. |
2017-06-28 |
2023-08-13 |
human |
| Lauren E Sweet, Joseph H Bisesi, E N Y Lei, Michael H W Lam, Stephen J Klain. The effects of bupropion on hybrid striped bass brain chemistry and predatory behavior. Environmental toxicology and chemistry. vol 35. issue 8. 2017-06-28. PMID:26748934. |
although bupropion altered the concentration of dopamine and many of the dopaminergic neurotransmitter metabolite concentrations in the brains on day 3 of the exposure, it did not alter the time to capture prey. |
2017-06-28 |
2023-08-13 |
human |
| Lauren E Sweet, Joseph H Bisesi, E N Y Lei, Michael H W Lam, Stephen J Klain. The effects of bupropion on hybrid striped bass brain chemistry and predatory behavior. Environmental toxicology and chemistry. vol 35. issue 8. 2017-06-28. PMID:26748934. |
this suggests that alteration of dopaminergic neurotransmitter concentrations in the hybrid striped bass brain does not alter a predator's ability to capture prey. |
2017-06-28 |
2023-08-13 |
human |
| Xiaona Zhang, Shuman Li, Cuicui Wang, Hua Tian, Wei Wang, Shaoguo R. Effects of monocrotophos pesticide on cholinergic and dopaminergic neurotransmitter systems during early development in the sea urchin Hemicentrotus pulcherrimus. Toxicology and applied pharmacology. vol 328. 2017-06-16. PMID:28479505. |
effects of monocrotophos pesticide on cholinergic and dopaminergic neurotransmitter systems during early development in the sea urchin hemicentrotus pulcherrimus. |
2017-06-16 |
2023-08-13 |
Not clear |
| Ahmad Seif Kanaan, Sarah Gerasch, Isabel García-García, Leonie Lampe, André Pampel, Alfred Anwander, Jamie Near, Harald E Möller, Kirsten Müller-Vah. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain : a journal of neurology. vol 140. issue 1. 2017-06-05. PMID:28007998. |
in view of (i) the close spatio-temporal synergy exhibited between excitatory, inhibitory and modulatory neurotransmitter systems; (ii) the crucial role played by glutamate (glu) in tonic/phasic dopaminergic signalling; and (iii) the interdependent metabolic relationship exhibited between glu and gaba via glutamine (gln); we postulated that glutamatergic signalling is related to the pathophysiology of gilles de la tourette syndrome. |
2017-06-05 |
2023-08-13 |
human |
| Yu-Chia Chen, Svetlana Semenova, Stanislav Rozov, Maria Sundvik, Joshua L Bonkowsky, Pertti Panul. A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity. The Journal of biological chemistry. vol 291. issue 42. 2017-05-22. PMID:27539857. |
a novel developmental role for dopaminergic signaling to specify hypothalamic neurotransmitter identity. |
2017-05-22 |
2023-08-13 |
zebrafish |
| Yu-Chia Chen, Svetlana Semenova, Stanislav Rozov, Maria Sundvik, Joshua L Bonkowsky, Pertti Panul. A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity. The Journal of biological chemistry. vol 291. issue 42. 2017-05-22. PMID:27539857. |
these results reveal a role for dopaminergic signaling in the regulation of neurotransmitter identity and a potential mechanism contributing to sleep disturbances in parkinson's disease. |
2017-05-22 |
2023-08-13 |
zebrafish |
| Florian Brugger, Kailash P Bhatia, Frank M C Besa. Valproate-Associated Parkinsonism: A Critical Review of the Literature. CNS drugs. vol 30. issue 6. 2017-04-11. PMID:27255404. |
several pathophysiological mechanisms, including altered gene expression and neurotransmitter signalling, enhanced neurodegeneration or unmasking subclinical dopaminergic degeneration, could theoretically lead to valproate-associated parkinsonism. |
2017-04-11 |
2023-08-13 |
Not clear |
| S Mohammad Ahmadi Soleimani, Hamed Ekhtiari, Jean Lud Cade. Drug-induced neurotoxicity in addiction medicine: From prevention to harm reduction. Progress in brain research. vol 223. 2017-03-07. PMID:26806769. |
most drugs of abuse have nonnegligible neurotoxic effects many of which are primarily mediated by several dopaminergic and glutamatergic neurotransmitter systems. |
2017-03-07 |
2023-08-13 |
Not clear |
| Santiago Perez-Lloret, María Cecilia Peralta, Francisco J Barrante. Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration. Expert opinion on pharmacotherapy. vol 17. issue 18. 2017-02-13. PMID:27785919. |
however, insufficient response to dopaminergic replacement therapy suggests the involvement of other neurotransmitter systems in the pathophysiology of pd. |
2017-02-13 |
2023-08-13 |
Not clear |
| Walter Swardfager, Joshua D Rosenblat, Meriem Benlamri, Roger S McIntyr. Mapping inflammation onto mood: Inflammatory mediators of anhedonia. Neuroscience and biobehavioral reviews. vol 64. 2016-12-27. PMID:26915929. |
as an exemplar, we consider the psychopathological domain of anhedonia, conceptualizing the relevance of inflammation (e.g., cellular immunity) and downstream processes (e.g., indoleamine 2,3-dioxygenase activation and oxidative inactivation of tetrahydrobiopterin) across rdoc units of analysis (e.g., catecholamine neurotransmitter molecules, nucleus accumbens medium spiny neuronal cells, dopaminergic mesolimbic and mesocortical reward circuits, animal paradigms, etc.). |
2016-12-27 |
2023-08-13 |
Not clear |
| R L Bell, S Hauser, Z A Rodd, T Liang, Y Sari, J McClintick, S Rahman, E A Englema. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction. International review of neurobiology. vol 126. 2016-12-27. PMID:27055615. |
pharmacologically and genetically, the focus will be on the neurotransmitter and neuropeptide systems that have received the most attention: cholinergic, dopaminergic, gabaergic, glutamatergic, serotonergic, noradrenergic, corticotrophin releasing hormone, opioid, and neuropeptide y. herein, we sought to place the p rat's behavioral and neurochemical phenotypes, and to some extent its genotype, in the context of the clinical literature. |
2016-12-27 |
2023-08-13 |
rat |
| Ngoc Thien Lam, Kartik Balachandra. The mechanobiology of drug-induced cardiac valve disease. Journal of long-term effects of medical implants. vol 25. issue 1-2. 2016-12-13. PMID:25955005. |
in general, these drugs have serotonergic, dopaminergic, or β-adrenergic activity, being either agonists or reuptake inhibitors of the aforementioned neurotransmitter pathways. |
2016-12-13 |
2023-08-13 |
Not clear |
| Robert M Kessler, Peter H Hutson, Barry K Herman, Marc N Potenz. The neurobiological basis of binge-eating disorder. Neuroscience and biobehavioral reviews. vol 63. 2016-12-13. PMID:26850211. |
human genetics and animal studies suggest that there are changes in neurotransmitter networks, including dopaminergic and opioidergic systems, associated with binge-eating behaviors. |
2016-12-13 |
2023-08-13 |
human |
| Sarah J Stednitz, Briana Freshner, Samantha Shelton, Tori Shen, Donovan Black, Ethan Gahta. Selective toxicity of L-DOPA to dopamine transporter-expressing neurons and locomotor behavior in zebrafish larvae. Neurotoxicology and teratology. vol 52. issue Pt A. 2016-10-12. PMID:26546233. |
increasing evidence suggests that the neurotransmitter dopamine may have a neurotoxic metabolic product (dopal) that selectively damages dopaminergic cells. |
2016-10-12 |
2023-08-13 |
zebrafish |
| Sarah Gerasch, Ahmad Seif Kanaan, Ewgeni Jakubovski, Kirsten R Müller-Vah. Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome. Frontiers in neuroscience. vol 10. 2016-09-27. PMID:27672358. |
it can be hypothesized that these beneficial effects are related to aripiprazole's adaptive pharmacological profile, which exhibits an influence on the dopaminergic as well as a number of other neurotransmitter systems. |
2016-09-27 |
2023-08-13 |
Not clear |
| Rodolphe Hajj, Aude Milet, Damien Toulorge, Nathalie Cholet, Julien Laffaire, Julie Foucquier, Sandra Robelet, Richard Mitry, Mickael Guedj, Serguei Nabirotchkin, Ilya Chumakov, Daniel Cohe. Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease. Scientific reports. vol 5. 2016-09-26. PMID:26542636. |
parkinson's disease (pd) is a progressive neurodegenerative disorder characterised by the loss of dopaminergic nigrostriatal neurons but which involves the loss of additional neurotransmitter pathways. |
2016-09-26 |
2023-08-13 |
rat |